for patients with cutaneous t-cell lymphomas ( mycosis fungoides and the sezary syndrome ) , a response rate of 45 % , with 10 % complete responses , was seen in patients treated with recombinant interferon alpha .
C0079773
cutaneous t-cell lymphomas
C0036920
sezary